Immunovant, Inc. (IMVT) Misses Q2 EPS by 4c
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.